KIAA0586 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.608800E-01
Normal-vs-Stage2
3.623600E-01
Normal-vs-Stage3
1.908760E-01
Normal-vs-Stage4
9.011200E-01
Stage1-vs-Stage2
8.080200E-01
Stage1-vs-Stage3
3.845700E-02
Stage1-vs-Stage4
4.073800E-01
Stage2-vs-Stage3
1.362210E-03
Stage2-vs-Stage4
1.957850E-01
Stage3-vs-Stage4
7.538000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.183000E-01
Normal-vs-AfricanAmerican
6.567200E-01
Normal-vs-Asian
2.425200E-01
Caucasian-vs-AfricanAmerican
7.844200E-01
Caucasian-vs-Asian
2.044000E-01
AfricanAmerican-vs-Asian
3.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.487000E-01
Normal-vs-Female
4.964800E-01
Male-vs-Female
7.281800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.126600E-01
Normal-vs-Age(41-60Yrs)
6.481800E-01
Normal-vs-Age(61-80Yrs)
3.549800E-01
Normal-vs-Age(81-100Yrs)
1.665410E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.351600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.406030E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.584500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.704000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.711970E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.120600E-01
Normal-vs-Daily Drinker
2.633000E-01
Normal-vs-Weekly Drinker
3.202000E-01
Normal-vs-Occasional Drinker
6.971400E-01
Normal-vs-Social Drinker
8.373800E-01
Non Drinker-vs-Daily Drinker
9.757400E-01
Non Drinker-vs-Weekly Drinker
8.794400E-01
Non Drinker-vs-Occasional Drinker
9.774400E-02
Non Drinker-vs-Social Drinker
2.187000E-01
Daily Drinker-vs-Weekly Drinker
9.104200E-01
Daily Drinker-vs-Occasional Drinker
1.437980E-01
Daily Drinker-vs-Social Drinker
2.046000E-01
Weekly Drinker-vs-Occasional Drinker
2.327200E-01
Weekly Drinker-vs-Social Drinker
3.136200E-01
Occasional Drinker-vs-Social Drinker
8.954200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.805360E-01
Normal-vs-Grade 2
8.586300E-02
Normal-vs-Grade 3
6.485700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.611000E-01
Grade 1-vs-Grade 3
7.887000E-01
Grade 1-vs-Grade 4
1.805360E-01
Grade 2-vs-Grade 3
7.507000E-01
Grade 2-vs-Grade 4
8.586300E-02
Grade 3-vs-Grade 4
6.485700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.728400E-01
Normal-vs-NonDiabetic
3.197200E-01
Diabetic-vs-NonDiabetic
9.110600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.683700E-02
Normal-vs-NoPancreatitis
3.739200E-01
Pancreatitis-vs-NoPancreatitis
1.751540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.520600E-01
Normal-vs-N1
3.623600E-01
N0-vs-N1
5.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.616800E-01
Normal-vs-TP53-NonMutant
8.510600E-01
TP53-Mutant-vs-TP53-NonMutant
2.819800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
